The US ballistic missile defence policy in the Baltic and Nordic regions

This article examines the implications of the deployment of the US ballistic missile defense (BMD) system in the Baltic and Nordic regions. These implications are to be considered to ensure Russia's military security. Using the structural-functional method, the authors analyse the internal structure of the US BMD in Europe, stages of its implementation, and its influence on the military equilibrium in the region. Being similar to other regional missile defence systems of the Pentagon, BMD in Europe increases the offensive capabilities of the US armed forces and its allies and in doing so, it stops performing a purely defensive mission declared by Washington. It is stressed that the deployment of mobile sea- and land-based BMD elements in the Baltic Sea region and Nordic countries will inevitably destabilize the strategic situation and may lead to a new round of arms race in the region. The efficacy of BMD in Europe is evaluated from the perspective of military technology. The system’s potential threats to Russia's military security and its armed forces are assessed. The article considers measures to enhance national security that could be taken by Russia provided the US plans to deploy BMD in Europe are fully implemented

Comparison of various lazaroid compounds for protection against ischemic liver injury

Lazaroids are a group of 21-aminosteroids that lack steroid action but have a potent cytoprotective effect by inhibiting iron-dependent lipid peroxidation. However, there have been conflicting reports on the effectiveness and potency of the various lazaroid compounds. In this study, we compared the effectiveness of three major lazaroids on warm liver ischemia in dogs using a 2-hr hepatic vascular exclusion model. The agents were given to the animals intravenously for 30 min before ischemia. The animals were divided into 5 groups: Control (n=10), no treatment; Group F (n=6), U-74006F (10 mg/kg); Group G (n=6), U-74389G (10 mg/kg); Group A1 (n=6), U-74500A (10 mg/kg); Group A2 (n=6), U-74500A (5 mg/kg). The effect of treatment was evaluated by two-week animal survival, hepatic tissue blood flow, liver function tests, blood and tissue biochemistry, and histological analyses. Animal survival in all treated groups was significantly improved compared with the control (83-100% versus 30%). Elevation of liver enzymes after reperfusion was markedly attenuated in treated groups, except for an early significant increase in Group G. Postreperfusion hepatic tissue blood flow was much higher in all treated animals (50% of the preischemic level vs. 25% in the control). Lazaroids, particularly U-74500A at 5 mg/kg (Group A2), suppressed adenine nucleotide degradation during ischemia and enhanced the resynthesis of high-energy phosphates after reperfusion. Although structural abnormalities in postreperfusion liver tissues were markedly ameliorated in all treated groups, Group A2 showed significantly less neutrophil infiltration. Liver injury from warm ischemia and reperfusion was attenuated with all lazaroid compounds, of which U-74500A at 5 mg/kg exhibited the most significant protective activity

Forming the Composition of Underground Coal Gasification Products in the Simulation of Various Heat and Mass Transfer Conditions in the Coal Seam

The mathematical model describing the heat and mass transfer processes in underground coal gasification is proposed. Numerical studies have allowed to determine the composition of gases depending on the temperature, pressure products of gasification, and the composition of the heated oxidant injected. Relations the composition of the concentration of combustible gas component of the oxidant injected: dry air, a mixture of oxygen, nitrogen and water vapor in different proportions were prepared. It is found that, depending on the oxygen content in the oxidizer low-temperature gasification mode is implemented (up to 15%). At higher values of the oxygen concentration in the oxidizer the high-temperature mode is realized, in which the fuel gas output increases significantly

In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients: Implications for the establishment and maintenance of donor cell chimerism following liver transplantation

Dendritic cell (DC) progenitors were propagated in liquid culture from nonparenchymal cells resident in normal mouse (B10.BR; H-2k, I-E+) liver in response to granulocyte-macrophage colony stimulating factor (GM-CSF). The liver-derived DC progenitors were MHC class II-/dim and did not express counter receptors for CTLA-4, a structural homologue of the Т cell activation molecule CD28. Following subcutaneous or intravenous injection, these liver-derived cells migrated to Т cell-dependent areas of lymph nodes and spleen of unmodified, allogeneic (BIO; H-2b; I-E_) recipients, where they were identified 1-5 days, and 1 and 2 months after injection by their strong surface expression of donor MHC class II (I-Ek) and their dendritic morphology. Maximal numbers of liver-derived DC in the spleen were recorded 5 days after injection. Both clusters of strongly donor MHC class II+ cells— and (more rarely) dividing cells—could also be identified, suggesting cell replication in situ. Using the same techniques employed to generate DC progenitors from normal liver, GM-CSF-stimulated cells were propagated for 10 days from the bone marrow and spleen of nonimmunosuppressed mice sacrificed 14 days after orthotopic liver transplantation (B10;H-2b → C3H;H-2k). Immunocytochemical staining for recipient and donor MHC class II phenotype revealed the growth both of host cells with DC characteristics, and of cells expressing donor alloantigens (I-Ab). These results are consistent with the growth, in response to GM-CSF, of donor-derived DC from progenitors seeded from the liver allograft to recipient lymphoid tissue. The functional activity of the progenitors of chimeric DC and the possible role of these cells in the establishment and maintenance of donor-specific tolerance following liver transplantation remain to be determined. © 1995 by Williams and Wilkins

Influence of the thermal factor on the composition of electron-beam high-entropy ALTiVCrNbMo coatings

This paper reports results of studying the element and phase compositions of electron-beam coatings based on the high-entropy alloy AlTiVCrNbMo, depending on the deposition temperature (in the range of 300...700 °С). The high-entropy alloys were melted in an arc furnace in an atmosphere of high-purity argon. Vacuum condensates of the high-entropy alloy (AlTiVCrNbMo) with a thickness of 3–5 µm were obtained in the vacuum setup UVN-2M-1 at a working vacuum of 5·10-5 mТоrr. The alloy evaporation was performed from the water-cooled ingot mold using an electron-beam gun with a power of 5 kW. Condensation of vapors of all the elements of the alloy was performed onto copper substrates at temperatures of 300, 500, 700 °C. Based on analysis of the element composition of materials of the target made of the high-entropy six-element alloy AlTiVCrNbMo and electron-beam coatings, based on it, we established the critical parameter (specific heat of vaporization of an element) that defined a selective change in the element composition. In accordance with a characteristic change in the composition of coatings of the multi-element high-entropy alloy, 3 groups of elements were distinguished: with a specific heat of evaporation of 280...350 kJ/mol (group 1), 420…460 kJ/mol (group 2), and 590…680 kJ/mol (group 3). It was shown that the formation of a single-phase coating of the high-entropy alloy (based on BCC of the crystalline lattice) occurs at the higher deposition temperature of 500...700 °C when the coating consists of not less than 5 elements. It was established that based on the conditions for an electron-beam process of materials formation, the results obtained can be divided into two types: those determined by the condition of evaporation of the target and those determined by the conditions of coating deposition. The density of flows of elements, evaporated from the target, is determined by their specific heat of evaporation. However, the ratio of atoms in the flow, derived in this way, may not be retained in the formed coating due to the secondary evaporation of elements from the growth surface. The obtained results allow us to substantiate principles for the selection of components for achieving the optimal element and phase compositions of high-entropy alloys.На основі аналізу елементного складу матеріалів мішені з високоентропійного шестиелементного сплаву AlTiVCrNbMo і електронно-променевих покриттів на його основі встановлено критичний параметр (питома теплота випаровування елемента), який визначає селективну зміну елементного складу. Показано, що формування однофазного покриття високоентропійного сплаву відбувається, коли до складу покриття входить не менше 5 елементів. Отримані результати дозволяють обґрунтувати принципи підбору компонент для досягнення оптимальних елементного та фазового складу високоентропійних сплавів

Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, awETN40

Background: Enhanced production of endothelin-1 (ET1), vasoconstrictive 21 amino acids produced by endothelial cells during ischemia and after reperfusion of the liver, is known to cause sinusoidal constriction and microcirculatory disturbances, which lead to severe tissue damage. Using a 2- hour hepatic vascular exclusion model in dogs, we tested our hypothesis that neutralization of ET-1 by monoclonal anti-ET-1 and anti-ET-2 antibody (AwETN40) abates vascular dysfunction and ameliorates ischemia/reperfusion injury of the liver. Study Design: After skeletonization, the liver was made totally ischemic by cross-clamping the portal vein, the hepatic artery, and the vena cava (above and below the liver). Venovenous bypass was used to decompress splanchnic and inferior systemic congestion. AwETN40, 5 mg/kg, was administered intravenously 10 minutes before ischemia (treatment group, n = 5). Nontreated animals were used as controls (control group, n = 10). Animal survival, hepatic tissue blood flow, liver function tests; total bile acid, high-energy phosphate, ET-1 levels, and liver histopathology were studied. Results: Treatment with AwETN40 improved 2-week animal survival from 30% to 100%. Hepatic tissue blood flow after reperfusion was significantly higher in the treatment group. The treatment significantly attenuated liver enzyme release, total bile acid, and changes in adenine nucleotides. Immunoreactive ET-1 levels in the hepatic venous blood of the control group showed a significant increase and remained high for up to 24 hours after reperfusion. Histopathologic alterations were significantly lessened in the treatment group. Conclusions: These results indicate that ET-1 is involved in ischemia/reperfusion injury of the liver, which can be ameliorated by the monoclonal anti-ET-1 and antiET-2 antibody AwETN40